Journal ArticleJACC Cardiovasc Imaging · June 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal ArticleInterdisciplinary Cardiovascular and Thoracic Surgery · May 1, 2024
OBJECTIVES: Use of radial artery as a second arterial graft, compared to a saphenous vein, in coronary artery bypass grafting (CABG) can improve late outcomes. However, the radial artery remains underutilized. We initiated a quality improvement (QI) initia ...
Full textCite
Journal ArticleCirc Cardiovasc Interv · May 2024
BACKGROUND: XC001 is a novel adenoviral-5 vector designed to express multiple isoforms of VEGF (vascular endothelial growth factor) and more safely and potently induce angiogenesis. The EXACT trial (Epicardial Delivery of XC001 Gene Therapy for Refractory ...
Full textLink to itemCite
Journal ArticleJ Nucl Cardiol · April 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
ConferenceJTCVS Tech · December 2023
OBJECTIVE: We developed a hybrid technique for repairing post-myocardial infarction (MI) ventricular septal defect (VSD) that combines infarct exclusion with patch and a nitinol-mesh septal occluder device (SOD) to provide a scaffold to support the damaged ...
Full textLink to itemCite
Journal ArticleClin Microbiol Infect · December 2023
BACKGROUND: Percutaneous mechanical aspiration (PMA) of intravascular vegetations is a novel strategy for management of patients with infective endocarditis (IE) who are at high risk of poor outcomes with conventional cardiac surgery. However, clear indica ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · October 2023
OBJECTIVE: After limited root/ascending with or without hemiarch repair for acute type A aortic dissection (ATAAD), 20% to 30% of patients require distal reintervention, frequently for arch pathology. In this report, we describe an institutional algorithm ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · August 25, 2023
Spontaneous coronary artery dissection (SCAD) is a rare but important nonatherosclerotic cause of acute coronary syndrome. Indications for revascularization and long-term outcomes of SCAD remain areas of active investigation. We report our experience with ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · August 2023
BACKGROUND: New therapies are needed for patients with refractory angina. Encoberminogene rezmadenovec (XC001), a novel adenoviral-5 vector coding for all 3 major isoforms of VEGF (vascular endothelial growth factor), demonstrated enhanced local angiogenes ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2023
BACKGROUND: Selective sinus replacement (SSR) allows a tailored repair approach in patients with sinus of Valsalva or asymmetric aortic root aneurysm. SSR avoids the need for coronary reimplantation for nondiseased sinuses and shortens operative time, alth ...
Full textLink to itemCite
Journal ArticleCell Stem Cell · January 5, 2023
The efficacy and safety of gene-therapy strategies for indications like tissue damage hinge on precision; yet, current methods afford little spatial or temporal control of payload delivery. Here, we find that tissue-regeneration enhancer elements (TREEs) i ...
Full textLink to itemCite
Journal ArticleJ Card Surg · December 2022
Historically, structural and anatomical imaging has been the mainstay in the diagnosis and management of cardiovascular diseases. In recent years there has been a shift toward increased use of functional imaging studies, including positron emission tomogra ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2022
BACKGROUND: Stent graft-induced new entry has been described in thoracic endovascular aortic repair for aortic dissection. The incidence of stent graft-induced aortic wall injury (SAWI) related to iatrogenic injury in nondissections is incompletely describ ...
Full textLink to itemCite
Journal ArticleCASE (Phila) · September 2022
• Right-sided IE is associated with IVDU. • Percutaneous debulking of TV vegetations can be a therapeutic option. • TEE can help guide debulking. • TEE can be used to monitor for and prevent complications. ...
Full textLink to itemCite
Journal ArticleFront Cardiovasc Med · 2022
BACKGROUND: The optimal delivery route to enhance effectiveness of regenerative therapeutics to the human heart is poorly understood. Direct intra-myocardial (IM) injection is the gold standard, however, it is relatively invasive. We thus compared targeted ...
Full textLink to itemCite
Journal ArticleCirculation · November 16, 2021
Introduction:
The optimal cardiac delivery route for stem cell and gene therapeutics is poorly understood. Direct intramyocardial (IM) injection has been proposed as the gold standard, however, it is ...
Full textCite
Journal ArticleOpen Forum Infect Dis · November 2021
We report the first case of Curvularia alcornii aortic pseudoaneurysm following bioprosthetic aortic valve replacement in an immunocompetent host. Infection was complicated by septic emboli to multiple organs. Despite aggressive surgical intervention and a ...
Full textOpen AccessLink to itemCite
Journal ArticleJACC Cardiovasc Imaging · June 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · May 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal ArticleInterdisciplinary Cardiovascular and Thoracic Surgery · May 1, 2024
OBJECTIVES: Use of radial artery as a second arterial graft, compared to a saphenous vein, in coronary artery bypass grafting (CABG) can improve late outcomes. However, the radial artery remains underutilized. We initiated a quality improvement (QI) initia ...
Full textCite
Journal ArticleCirc Cardiovasc Interv · May 2024
BACKGROUND: XC001 is a novel adenoviral-5 vector designed to express multiple isoforms of VEGF (vascular endothelial growth factor) and more safely and potently induce angiogenesis. The EXACT trial (Epicardial Delivery of XC001 Gene Therapy for Refractory ...
Full textLink to itemCite
Journal ArticleJ Nucl Cardiol · April 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
ConferenceJTCVS Tech · December 2023
OBJECTIVE: We developed a hybrid technique for repairing post-myocardial infarction (MI) ventricular septal defect (VSD) that combines infarct exclusion with patch and a nitinol-mesh septal occluder device (SOD) to provide a scaffold to support the damaged ...
Full textLink to itemCite
Journal ArticleClin Microbiol Infect · December 2023
BACKGROUND: Percutaneous mechanical aspiration (PMA) of intravascular vegetations is a novel strategy for management of patients with infective endocarditis (IE) who are at high risk of poor outcomes with conventional cardiac surgery. However, clear indica ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · October 2023
OBJECTIVE: After limited root/ascending with or without hemiarch repair for acute type A aortic dissection (ATAAD), 20% to 30% of patients require distal reintervention, frequently for arch pathology. In this report, we describe an institutional algorithm ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · August 25, 2023
Spontaneous coronary artery dissection (SCAD) is a rare but important nonatherosclerotic cause of acute coronary syndrome. Indications for revascularization and long-term outcomes of SCAD remain areas of active investigation. We report our experience with ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Interv · August 2023
BACKGROUND: New therapies are needed for patients with refractory angina. Encoberminogene rezmadenovec (XC001), a novel adenoviral-5 vector coding for all 3 major isoforms of VEGF (vascular endothelial growth factor), demonstrated enhanced local angiogenes ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2023
BACKGROUND: Selective sinus replacement (SSR) allows a tailored repair approach in patients with sinus of Valsalva or asymmetric aortic root aneurysm. SSR avoids the need for coronary reimplantation for nondiseased sinuses and shortens operative time, alth ...
Full textLink to itemCite
Journal ArticleCell Stem Cell · January 5, 2023
The efficacy and safety of gene-therapy strategies for indications like tissue damage hinge on precision; yet, current methods afford little spatial or temporal control of payload delivery. Here, we find that tissue-regeneration enhancer elements (TREEs) i ...
Full textLink to itemCite
Journal ArticleJ Card Surg · December 2022
Historically, structural and anatomical imaging has been the mainstay in the diagnosis and management of cardiovascular diseases. In recent years there has been a shift toward increased use of functional imaging studies, including positron emission tomogra ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2022
BACKGROUND: Stent graft-induced new entry has been described in thoracic endovascular aortic repair for aortic dissection. The incidence of stent graft-induced aortic wall injury (SAWI) related to iatrogenic injury in nondissections is incompletely describ ...
Full textLink to itemCite
Journal ArticleCASE (Phila) · September 2022
• Right-sided IE is associated with IVDU. • Percutaneous debulking of TV vegetations can be a therapeutic option. • TEE can help guide debulking. • TEE can be used to monitor for and prevent complications. ...
Full textLink to itemCite
Journal ArticleFront Cardiovasc Med · 2022
BACKGROUND: The optimal delivery route to enhance effectiveness of regenerative therapeutics to the human heart is poorly understood. Direct intra-myocardial (IM) injection is the gold standard, however, it is relatively invasive. We thus compared targeted ...
Full textLink to itemCite
Journal ArticleCirculation · November 16, 2021
Introduction:
The optimal cardiac delivery route for stem cell and gene therapeutics is poorly understood. Direct intramyocardial (IM) injection has been proposed as the gold standard, however, it is ...
Full textCite
Journal ArticleOpen Forum Infect Dis · November 2021
We report the first case of Curvularia alcornii aortic pseudoaneurysm following bioprosthetic aortic valve replacement in an immunocompetent host. Infection was complicated by septic emboli to multiple organs. Despite aggressive surgical intervention and a ...
Full textOpen AccessLink to itemCite
Chapter · January 1, 2021
After surgical repair for acute aortic syndromes, whether with open, endovascular or hybrid approaches, immediate post-operative and long-term monitoring require a patient specific approach. In the acute phase, dissection, in particular, can create a casca ...
Full textCite
Journal ArticleJ Surg Case Rep · December 2020
Gynecological carcinosarcomas are aggressive tumors with rare occurrence and high rates of metastases. We present the case of a 49-year-old woman with vaginal bleeding and abdominal distension who was found to have a large ovarian carcinosarcoma invading t ...
Full textLink to itemCite
Journal ArticleJ Card Surg · November 2020
Implanting an inverted aortic valve prosthesis in the mitral position has shown to be a viable solution for a small mitral annulus. We describe a case of implanting an inverted in the mitral prosthesis in the aortic position in a patient with an excessivel ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · June 2020
BACKGROUND: Patients with bicuspid aortic valve stenosis (BAV) were excluded from all the trileaflet aortic valve stenosis (TAV) pivotal trials, and therefore, their outcomes are not clearly defined. The aim of the study was to evaluate the outcomes of tra ...
Full textLink to itemCite
Journal ArticleJ Invasive Cardiol · July 2019
BACKGROUND: Alternative access (AA) is still required for a significant proportion of patients undergoing transcatheter aortic valve replacement (TAVR). We sought to compare the clinical outcomes of patients undergoing AA vs transfemoral (TF) access. METHO ...
Link to itemCite
Journal ArticleCirc Res · April 12, 2019
RATIONALE: Although rare cardiomyogenesis is reported in the adult mammalian heart, whether this results from differentiation or proliferation of cardiomyogenic cells remains controversial. The tumor suppressor genes RB1 (retinoblastoma) and CDKN2a (cyclin ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2018
BACKGROUND: Results of hybrid arch repair (HAR) using the native zone 0 proximal landing zone (PLZ) have been unsatisfactory in many series, especially in the setting of ascending aortic dilation (>4.0 cm). This study reports early and late outcomes of pla ...
Full textLink to itemCite
Journal ArticlePerfusion · March 2018
We present a case series of seven patients with suspected cold agglutinin antibodies, discovered after initiation of bypass. Laboratory analysis of blood samples intraoperatively determined the cause of the aggregation to be rouleaux formation in three of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 6, 2016
BACKGROUND: Pim1 kinase plays an important role in cell division, survival, and commitment of precursor cells towards a myocardial lineage, and overexpression of Pim1 in ckit+ cardiac stem cells (CSCs) enhances their cardioreparative properties. OBJECTIVES ...
Full textLink to itemCite
Journal ArticleJ Extra Corpor Technol · June 2016
The presence of cold agglutinins (CA) during cardiac surgery with cardiopulmonary bypass usually creates the need for an altered surgical plan. In this case, the CA were discovered after the initiation of bypass, limiting the time, and cardioplegia solutio ...
Link to itemCite
Journal ArticleAnn Thorac Surg · December 2015
Carcinoid tumors rarely metastasize to the heart, and previous reports involved the myocardium only. We present a case of carcinoid tumor metastatic to the right ventricle (RV) and tricuspid valve. Preoperative cardiac magnetic resonance imaging (CMR) show ...
Full textLink to itemCite
Journal ArticleCirculation Research · July 18, 2014
Background:
A cell combination of human mesenchymal stem cells (MSCs) and c-kit+ cardiac stem cells (CSCs) improves left ventricular (LV) performance to a greater degree than MSCs alone in post myocar ...
Full textCite
Journal ArticleCirc Res · April 11, 2014
RATIONALE: Transendocardial stem cell injection (TESI) with mesenchymal stem cells improves remodeling in chronic ischemic cardiomyopathy, but the effect of the injection site remains unknown. OBJECTIVE: To address whether TESI exerts its effects at the si ...
Full textLink to itemCite
Journal ArticleJAMA · January 1, 2014
IMPORTANCE: Whether culture-expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy is controversial. OBJECTIVE: To demonstrate the safety of transendocardial stem cell injection with ...
Full textLink to itemCite
Journal ArticleJournal of the American Heart Association · June 1, 2013
Intramyocardial injection of mesenchymal stem cells (MSCs) in chronic ischemic cardiomyopathy is associated with reverse remodeling in experimental models and humans. Here, we tested the hypothesis that allogeneic MSC therapy drives ventricular remodeling ...
Cite
Journal ArticleJ Am Heart Assoc · May 17, 2013
BACKGROUND: Intramyocardial injection of mesenchymal stem cells (MSCs) in chronic ischemic cardiomyopathy is associated with reverse remodeling in experimental models and humans. Here, we tested the hypothesis that allogeneic MSC therapy drives ventricular ...
Full textLink to itemCite
Journal ArticleCirculation · January 15, 2013
BACKGROUND: Because mesenchymal stem cells (MSCs) induce proliferation and differentiation of c-kit(+) cardiac stem cells (CSCs) in vivo and in vitro, we hypothesized that combining human (h) MSCs with c-kit(+) hCSCs produces greater infarct size reduction ...
Full textLink to itemCite
Journal ArticleCirculation Research · August 3, 2012
Background:
Mesenchymal stem cells (MSCs) improve ventricular function post MI
Hypothesis:
Transendocardial stem c ...
Full textCite
Journal ArticleNat Protoc · July 12, 2012
Sustainable and reproducible large animal models that closely replicate the clinical sequelae of myocardial infarction (MI) are important for the translation of basic science research into bedside medicine. Swine are well accepted by the scientific communi ...
Full textLink to itemCite
Journal ArticleHeart · November 2011
OBJECTIVE: While patients with cardiac implantable electronic devices could benefit from magnetic resonance (MR) imaging, the presence of such devices has been designated as an absolute contraindication to MR. Although scanning algorithms are proposed for ...
Full textLink to itemCite
Journal ArticleCirc Res · September 30, 2011
Mesenchymal stem cells (MSCs) are a prototypical adult stem cell with capacity for self-renewal and differentiation with a broad tissue distribution. Initially described in bone marrow, MSCs have the capacity to differentiate into mesoderm- and nonmesoderm ...
Full textLink to itemCite
Journal ArticleCirc Res · April 1, 2011
RATIONALE: Transcatheter, intramyocardial injections of bone marrow-derived cell therapy produces reverse remodeling in large animal models of ischemic cardiomyopathy. OBJECTIVE: We used cardiac MRI (CMR) in patients with left ventricular (LV) dysfunction ...
Full textLink to itemCite
Journal ArticleAm Heart J · March 2011
Although there is tremendous interest in stem cell (SC)-based therapies for cardiomyopathy caused by chronic myocardial infarction, many unanswered questions regarding the best approach remain. The TAC-HFT study is a phase I/II randomized, double-blind, pl ...
Full textLink to itemCite
Journal ArticleExpert Opin Pharmacother · January 2004
The increasing burden of cardiovascular diseases in developed, as well as developing countries, underscores the need for the more widespread and appropriate use of aspirin in secondary prevention of occlusive vascular events during acute evolving myocardia ...
Full textLink to itemCite
ConferenceJ Cardiovasc Electrophysiol · September 2003
Randomized clinical trials are the gold standard for the evaluation of new therapies. However, in the early years of pacing, the observational benefits were so great and the lifesaving benefits to patients so readily obvious that randomized trials were not ...
Full textLink to itemCite